Skip to Main Content
An official website of the United States government
Scheduled Maintenance: CDAS will be undergoing maintenance on Saturday, February 7th from 7:30 AM to 9:30 AM U.S. Eastern Standard Time for updates to the website. During this time you may experience intermittent downtime.

Approved PLCO Projects

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Reset
Showing Most Recent
1101-1120 of 1488
Name Principal Investigator Institution Study Date Approved Project ID
KIR/HLA/MIR148A variation and risk of prostate cancer Stella Koutros NCI, DCEG, OEEB PLCO Mar 9, 2011 2011-0039
Mitochondrial DNA Copy Number and Prostate Cancer Risk Sonja Berndt NCI, DCEG, OEEB PLCO Mar 9, 2011 2011-0037
Risk of multiple myeloma in relation to plasma adipokine levels: a nested case-control study in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Jonathan Hofmann DCEG - Other PLCO Mar 9, 2011 2011-0028
Prostate Cancer Survival in PLCO: The effect of screening Paul Pinsky NCI, DCP, EDRG PLCO Mar 3, 2011 2010-0301
Risk factors for endometrial cancer in black and white women in the Epidemiology of Endometrial Cancer Consortium (E2C2) Sara Olson Memorial Sloan-Kettering Cancer Center PLCO Feb 2, 2011 2010-0290
Oxford Pooling Project: Prostate (endogenous hormones and nutritional biomarkers) Amanda Black NCI, DCEG, EBP PLCO Jan 31, 2011 2010-0320
Inflammatory Markers and Subsequent Risk of Prostate Cancer Ann Hsing NCI, DCEG, HREB PLCO Jan 20, 2011 2010-0034
Side-effects and complications of prostate biopsies, radical prostatectomies and prostate cancer diagnoses within the PLCO Trial Amanda Black NCI, DCEG, EBP PLCO Nov 23, 2010 2010-0265
Arylamine hemoglobin (Hgb)-adducts and bladder cancer risk in never-smokers within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) Jonine Figueroa NCI PLCO Nov 22, 2010 2010-0113
Inflammation markers and risk of endometrial and ovarian cancer Nicolas Wentzensen MD NCI PLCO Nov 18, 2010 2010-0211
Inflammatory Markers and Smoking-Associated Cancers Meredith Shiels NCI PLCO Nov 18, 2010 2010-0201
Prospective Oral HPV Detection and Risk of Head and Neck Cancers Ilir Agalliu Other (Specify) PLCO Nov 18, 2010 2010-0153
Estimation of sensitivity of chest x-ray and cancer preclinical sojourn time for the lung component of the PLCO trial Ping Hu NCI, DCP, BRG PLCO Oct 22, 2010 2010-0076
Estimation of Mean Sojourn and Lead Time and Sensitivity in the Ovarian Component of the PLCO Trial Jian-Lun Xu NCI, DCP, BRG PLCO Oct 22, 2010 2010-0077
Does compliance with screening exams and forms completion differ by smoking status in PLCO? Pamela Marcus NCI, DCP, BRG PLCO Oct 22, 2010 2010-0158
Sibship size and site- and morphology-specific adult cancer risk Claire Vajdic University of New South Wales PLCO Sep 27, 2010 2010-0232
Accuracy of colonoscopy self-report Paul Doria-Rose NCI, DCP PLCO Sep 27, 2010 2010-0264
Non-Compliance Adjustment Applying Instrumental Variable Approach (CES) to Prostate Mortality Data Timothy Church University of Minnesota PLCO Sep 27, 2010 2010-0273
Angiogenic Profile and Risk of Breast Cancer in Postmenopausal Women Roni Falk NCI PLCO Sep 24, 2010 2010-0205
Serum Vitamin D and Risk of Bladder Cancer Alison Mondul NCI PLCO Sep 23, 2010 2010-0178